Name: Renal Failure
Brand: Nova Science Publishers, Inc
SKU: 9781536102840
Price: 97.99 GBP
Availability: InStock

Renal Failure

Diagnosis, Management & Potential Complications

Edited by: Masayoshi Yamaguchi

Published by Nova Science Publishers, Inc

In Stock

£97.99

Format: Paperback
Pages: 85
ISBN: 9781536102840
Publication Date: 01-Dec-2016

Subjects:
Haematology

Quantity

This book introduces the advanced topics regarding renal failure including manifold findings of physiologic, pathophysiologic and clinical aspects in the kidney. The kidney plays a crucial physiologic role in the regulation of urinary formation, fluid balance, nutrition metabolism, blood pressure and other aspects in the living body. Renal failure is a condition of a decline or loss of kidney function due to deficiency of functioning nephrons. Acute renal failure is a syndrome, which is characterized by acute decline or loss of kidney function due to temporary disfunctioning or blocking of nephrons. Acute renal failure is a reversible condition and is a secondary manifestation, a complication of another underlying critical illness. Chronic renal failure is a condition of slow, gradual decline of kidney function due to irreversible destruction of nephrons. This book provides recent information concerning acute and chronic renal failure in clinical aspects, and is constituted in five chapters.

Masayoshi Yamaguchi, Ph.D., IOM, FAOE, DDG, DG, is Adjunct Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA (2013 - ). Dr. Yamaguchi is engaged in the fields of endocrinology and cell signaling since 1971, and these researches are developed in the aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology. Dr Yamaguchi has an interesting for cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetes and diabetic osteoporosis, cancer biology, and cancer cell bone metastasis. Dr. Yamaguchi discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001). Dr Yamaguchi generated regucalcin transgenic rats, which were registered as international patents including USA, EU and Japan, and this animal was found to induce osteoporosis and hyperlipidemia. Moreover, Dr. Yamaguchi proposed the potential role of regucalcin as a key suppressor protein in carcinogenesis. Thus far, Dr Yamaguchi published over 550 English articles to professional journals with peer-review, and registered over 20 national and international patents.